Scandinavian Medical Solutions A/S
SMSMED.CO · CPH
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | DKK 123 | DKK 123 | DKK 124 | DKK 103 |
| % Growth | -0% | -1.1% | 21% | – |
| Cost of Goods Sold | DKK 107 | DKK 110 | DKK 107 | DKK 89 |
| Gross Profit | DKK 16 | DKK 13 | DKK 17 | DKK 13 |
| % Margin | 13.1% | 10.2% | 13.9% | 12.8% |
| R&D Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| G&A Expenses | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| SG&A Expenses | DKK 11 | DKK 12 | DKK 8 | DKK 8 |
| Sales & Mktg Exp. | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 0 | DKK 4 | DKK 0 | DKK 0 |
| Operating Expenses | DKK 11 | DKK 16 | DKK 8 | DKK 8 |
| Operating Income | DKK 5 | -DKK 3 | DKK 9 | DKK 5 |
| % Margin | 4.3% | -2.8% | 7.4% | 4.5% |
| Other Income/Exp. Net | -DKK 2 | DKK 1 | -DKK 2 | -DKK 1 |
| Pre-Tax Income | DKK 3 | -DKK 3 | DKK 7 | DKK 3 |
| Tax Expense | DKK 1 | DKK 1 | DKK 2 | DKK 1 |
| Net Income | DKK 2 | -DKK 2 | DKK 5 | DKK 3 |
| % Margin | 1.9% | -1.9% | 4.2% | 2.6% |
| EPS | 0.086 | -0.085 | 0.19 | 0.096 |
| % Growth | 200.7% | -144.7% | 97.9% | – |
| EPS Diluted | 0.086 | -0.085 | 0.19 | 0.096 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 27 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | -DKK 1 | DKK 2 | DKK 1 | DKK 0 |
| Interest Expense | DKK 1 | DKK 1 | DKK 4 | DKK 1 |
| Depreciation & Amortization | DKK 5 | DKK 4 | DKK 4 | DKK 3 |
| EBITDA | DKK 9 | DKK 1 | DKK 14 | DKK 7 |
| % Margin | 7.2% | 0.5% | 11.5% | 6.5% |